Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
36Kr Holdings (TBA) | Credit Suisse/ CICC | $100.00 | n.a. | |||
4D Molecular Therapeutics (DDDD) | Goldman Sachs/ Evercore ISI/ William Blair | $100.00 | n.a. | |||
Aesthetic Medical International Holdings Group (AIH) | Cantor/ Haitong International/ Prime Number Capital | $80.00 | n.a. | |||
Cabaletta Bio (CABA) | Morgan Stanley/ Cowen and Company/ Evercore Group | $100.00 | n.a. | |||
Galileo Acquisition (GLEO.U) (u) | EarlyBirdCapital | 10.00 | $10.00 | $10.00 | $100.00 | n.a. |
Oyster Point Pharma (OYST) | J.P. Morgan/ Cowen/ Piper Jaffray | $85.00 | n.a. | |||
Phathom Pharmaceuticals (PHAT) | Goldman Sachs/ Jefferies/ Evercore ISI | $100.00 | n.a. | |||
REED Ltd. (REEY) | ViewTrade Securities | 2.50 | $4.00 | $4.00 | $10.00 | n.a. |
Youdao (DAO) | Citigroup/ Morgan Stanley | $300.00 | n.a. | |||
n.a. (not available) | ||||||
u = unit offering | ||||||
Postponed | ||||||
ADC Therapeutics SA (ADCT) | Morgan Stanley/ BofA Merrill Lynch/ Cowen | 8.16 | $23.00 | $26.00 | $200.02 | 1-Star |
Monopar Therapeutics (MNPR) | JonesTrading | 4.44 | $8.00 | $10.00 | $40.00 | 1-Star |
Withdrawn | ||||||
ADC Therapeutics SA (ADCT) | Morgan Stanley/ BofA Merrill Lynch/ Cowen | 8.16 | $23.00 | $26.00 | $200.02 | S/O |
We Co. (WE) | J.P. Morgan/ Goldman Sachs/ BofA Merrill Lynch/ Barclay/ Citigroup/ Credit Suisse// HSBC Securities/ UBS Securities/ Wells Fargo Securities | $1,000.00 | S/O | |||
New Terms | ||||||
HBT Financial (HBT) | Keefe, Bruyette & Woods (A Stifel Company)/ J.P. Morgan | 8.30 | $17.00 | $19.00 | $149.40 | S/O |
HYLETE (HYLT) | Maxim Group LLC | $8.00 | $10.00 | $17.25 | S/O | |
Karat Packaging (KRAT) | National Securities | 5.00 | $7.00 | $9.00 | $40.00 | S/O |
Vir Biotechnology (VIR) | Goldman Sachs/ J.P. Morgan/ Cowen/ Barclays | 7.14 | $20.00 | $22.00 | $150.02 | S/O |
S/O (Subscribers Only) | ||||||
IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
Week of Sept. 30, 2019 | Manager(s) | Offered | Raised | Price | 10/4/19 | Change |
Aprea Therapeutics (APRE) | J.P. Morgan/ Morgan Stanley/ RBC Capital Markets | 5.67 | $85.00 | $15.00 | $19.07 | 27.13% |
Viela Bio (VIE) | Goldman Sachs/ Morgan Stanley/ Cowen | 7.90 | $150.10 | $19.00 | $23.12 | 21.68% |
MetroCity Bankshares (MCBS) | Keefe, Bruyette & Woods (A Stifel Company)/ Raymond James | 1.94 | $26.18 | $13.50 | $13.40 | -0.74% |
Frequency Therapeutics (FREQ) | J.P. Morgan/ Goldman Sachs/ Cowen | 6.00 | $84.00 | $14.00 | $13.49 | -3.64% |